Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank75
3Y CAGR-31.4%
5Y CAGR+33.6%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
-31.4%/yr
vs +53.1%/yr prior
5Y CAGR
+33.6%/yr
Recent deceleration
Acceleration
-84.5pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.74M | -64.0% |
| 2024 | $15.93M | +21.0% |
| 2023 | $13.17M | -26.0% |
| 2022 | $17.79M | +768.8% |
| 2021 | $2.05M | +51.8% |
| 2020 | $1.35M | +684.3% |
| 2019 | $172000.00 | -94.7% |
| 2018 | $3.24M | +580.9% |
| 2017 | $476000.00 | +496.7% |
| 2016 | $-120000.00 | - |